Table 1

Characteristics of Patients with Newly Diagnosed Type 2 Diabetes for Opportunistic Targeted Screening (n = 359) and Clinical Diagnosis (n = 206) Groups at Baseline and After Follow-up

CharacteristicBaselineFollow-up
Opportunistic Targeted ScreeningClinical DiagnosisP ValueOpportunistic Targeted ScreeningClinical DiagnosisP Value
Age, mean (SD), y61.8 (7.8)59.0 (8.1)<.001
Sex (male), No. (%)175 (48.7)118 (57.3).05
Follow-up, mean (SD), y7.7 (2.4)7.1 (2.7).01
History of macrovascular disease,a No. (%)88 (24.5)24 (11.7)<.001
  Ischemic heart disease, No. (%)44 (12.3)8 (3.9).001
  Myocardial infarction, No. (%)26 (7.2)11 (5.3).38
  Stroke, No. (%)12 (3.3)3 (1.5).18
  Other, No. (%)24 (6.7)11 (5.3).52
History of microvascular disease,a No. (%)63 (17.5)24 (11.7).06
  Retinopathy, No. (%)1 (0.3)3 (1.7).12
  Neuropathy, No. (%)6 (1.7)8 (3.9).10
  Nephropathy, No. (%)57 (16.9)13 (7.1).002
Blood glucose control
  FPG, mean (SD), mmol/L8.8 (2.9)12.9 (5.0)<.0017.9 (1.7)8.2 (2.2).06
  HbA1c, mean (SD),b mmol/mol55 (17)74 (28)<.00151 (10)54 (12).001
  HbA1c, mean (SD),b %7.2 (1.6)8.9 (2.5)<.0016.8 (0.9)7.1 (1.1).001
CVD risk factors
  Current smoking, No. (%)66 (19.3)41 (21.9).4745 (13.5)29 (15.8).48
  Systolic blood pressure, mean (SD), mm Hg153 (20)147 (21).004145 (18)144 (17).59
  Diastolic blood pressure, mean (SD), mm Hg86 (10)85 (11).3380 (10)81 (9).16
  BMI, mean (SD), kg/m230.5 (4.7)29.7 (5.0).0729.9 (4.7)29.6 (4.6).51
  Total cholesterol, mean (SD), mmol/L6.0 (1.2)6.0 (1.4).384.7 (1.1)4.7 (1.1).58
  LDL cholesterol, mean (SD), mmol/L3.7 (1.1)3.8 (1.2).722.6 (1.0)2.7 (0.9).86
  Plasma creatinine, mean (SD), mmol/L88.7 (18.1)84.1 (17.3).00489.4 (24.5)87.4 (19.9).32
  • Abbreviations: BMI = body mass index; CVD = cardiovascular disease; FPG = fasting plasma glucose; HbA1c = hemoglobin A1c; LDL = low-density lipoprotein.

  • a Some patients had multiple events.

  • b Missing at baseline = 201 in opportunistic targeted screening group; 126 in clinical diagnosis group.